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Abstract
Background: Influenza and Influenza like illness are representative 
of a class of epidemic infectious diseases that have important public 
health implications. Early detection via biosurveillance can speed life-
saving public heath responses. In the United States, biosurveillance is 
typically conducted using ICD9 coded visit diagnoses and uncoded 
chief complaint data. 
Objective: To determine the accuracy of ICD9 diagnoses using labo-
ratory confirmed cases as the gold standard.
Design: A six-year retrospective cohort study.
Setting: A tertiary referral center.
Patients: All 3,825 patients with an ICD9-CM diagnosis of Influenza 
and all 1455 patients with laboratory confirmed Influenza.
Results: Of the 3,828 patients assigned ICD9-CM visit codes indica-
ting a diagnosis of Influenza, 2,825 were not confirmed by laboratory 
testing and 1,003 patients under went laboratory testing. Only 664 
(66.2%) tested positive for Influenza. Of the 1,455 patients who tested 
positive for Influenza 45.6% were identified by ICD9-CM code.
Conclusion: ICD9-CM had a low 66.2% Positive Predictive Value 
(precision) for Influenza and a low 45.6% Sensitivity (recall) for In-
fluenza in patients tested for Influenza. ICD9 coded visit diagnoses/
claims data are insufficient alone to serve as the basis for Influenza 
Surveillance.
Primary Funding Source: CDC grants PH00022 and HK00014.
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Introduction
Influenza is a health threat which presents in 
yearly outbreaks, resulting in between 250,000 
and 500,000 dealths a year out of approxima-
tely three to five million cases. Pandemics (larger 
outbreaks) are less frequent. [1] Some forms of 
Influenza are more virulent such as H1N1. Many 
agents of Bioterrorism and natural epidemics such 
as H1N1 and Avian Influenza present as Influenza-
like illnesses. The CDC defines an influenza-like ill-
ness as fever plus either cough and/or sore throat 
in the absence of a known cause other than in-
fluenza. [2] In a systematic review of the literatu-
re on the clinical diagnosis of human influenza, 
no sign or symptom was useful in differentiating 
between influenza and a similar influenza-like ill-
ness, for example an Anthrax attack, when all 
age groups were included. [3] This can be an im-
portant consideration for the planning of a pu-
blic health response. For patients over 60 years 
of age the combination of fever, cough, and the 
acute onset of symptoms had a likelihood ratio of 
5:4 for the diagnosis of influenza versus a similar 
influenza-like illness. 
In the United States the Biosense system uses 
ICD9-CM codes and the data from chief complaint 
fields to perform daily biosurveillance. Information 
received can be reported to the CDC’s emergen-
cy operations center and can then trigger a public 
health response. In Europe, researchers have also 
advocated ontology based biosurveillance for use in 
surveilling antibiotic resistance in the Artemus pro-
ject led by Lovis et al. [4] 
In a prior study, we showed that whole record 
biosurveillance using SNOMED CT and natural lan-
guage processing (NLP) was superior to chief com-
plaint surveillance alone for Influenza surveillance. 
[5] In that study NLP using SNOMED CT had a sen-
sitivity of 92.9%. It was also previously reported 
by Elkin et al that only 8% of patients diagnosed 
with Influenza undergo laboratory testing. We also 
showed that SNOMED CT had good content cove-
rage of the information found in chief complaint 
fields. [6] 
The safety of the public health is a global and 
ubiquitous responsibility. Detecting an influenza 
epidemic early can trigger a public health response 
and save lives. For example, timely vaccination can 
prevent further cases and antiviral treatment can 
reduce mortality by as much as 36%. [67] Influenza 
biosurveillance is an important part of global health 
strategy. Biosurveillance techniques should be opti-
mized and continuously improved by using the most 
appropriate and accurate methods available. In this 
study we determine the accuracy of ICD9 encoded 
visit diagnoses, one of the pillars of current U.S. 
influenza biosurveillance strategy, using laboratory 
confirmed cases as the gold standard
Methods
This six year retrospective cohort study was ap-
proved by the Institutional Review Board (IRB# 
1836-05). Cases came primarily from Minneso-
ta, Wisconsin, North Dakota, South Dakota, and 
Iowa. No hospital or outpatient locations were 
excluded from the study (e.g. ED, Inpatient, Out-
patient, etc.).
3,828 eligible patients were all patients who 
were diagnosed with Influenza by ICD9-CM co-
ding (ICD9-CM codes 487 and its sub-codes 487.
XX) between October 2000 and March 2006. Pa-
tients are consented once for use of their clinical 
record data and are approached to ensure con-
tinued consent as they present for each annual 
visit. Only patients who have not denied consent 
for the use of their clinical record were included 
in this study. 
These patients were compared by medical record 
number with a database of patients laboratory tes-
ted for Influenza. All patients were either tested by 
viral culture or by polymerase chain reaction (PCR). 
Testing was for both Influenza A and for Influenza 
B. There were 1,455 patients who were tested and 
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tested positive for Influenza in the total population 
during the same time period.
The data was analyzed to determine the positive 
predictive value and sensitivity of ICD9-CM codes 
for the Identification of true Influenza cases
Results
20,068 patients were enrolled in the study and of 
these 17,243 patients were tested for Influenza. In 
our population of patients seen from October 2000 
and March 2006, 1,455 patients tested positive for 
Influenza. Of these cases, 664 were diagnosed by 
ICD9-CM code.
Of the population of 3,828 patients that had 
ICD9-CM diagnoses of Influenza, 1,003 were labo-
ratory tested for Influenza. Of the 1,003 patients 
laboratory tested for influenza, 664 tested positive 
and 339 tested negative (Figure 1).
The analysis of the data showed that ICD9-CM 
had a sensitivity (recall) of 45.6% and a positive 
predictive value (precision) of 66.2% for the iden-
tification and retrospective surveillance of Influen-
za (Table 1). The Negative predictive value and the 
Specificity for ICD9 were good at 95.1% and 97.9% 
respectively. 
Limitations
This data was from one large academic medical 
institution (Mayo Clinic) and in that way may not 
generalize. Respiratory Syncytial Virus testing was 
done very uncommonly and may account for some 
portion of the iCD9-CM codes for Influenza that 
tested negative.
Discussion
ICD9-CM encoded visit diagnoses yielded subop-
timal results in their ability to identify true cases 
of Influenza. From our data, ICD9-CM encoded 
visit diagnoses alone should not be used for the 
biosurveillance of Influenza or Influenza like illness. 
Likewise, biosurveillance relying on laboratory re-
sults alone would also have low sensitivity (though 
high specificity) - we have previously found that only 
8% of patients who are diagnosed with Influenza 
actually have confirmatory laboratory testing. 
Biosurveillance is an activity that needs to favor 
Sensitivity and ICD9 has been shown in this experi-
ment to be insensitive. Clearly, more complex mo-
dels are needed.
In Georgia, the current U.S. influenza biosurvei-
llance using chief complaint data and ICD9 coded vi-
sit data has a sensitivity of 19.1% and a positive pre-
Figure 1: Enrollment and results flowchart.
20,068 Patients Enrolled
17,243
Tested for 
Influenza
1,455 
Tested 
Positive for 
Influenza
15,449 
Tested 
Negative for 
Influenza
2,825 
Patients not 
tested for 
influenza
3,828 Patients 
Had ICD9-
CM codes for 
Influenza
1,003 Underwent Laboratory 
testing for Influenza
339 Patients 
Tested Negative 
for Influenza
664 Patients 
Tested Positive for 
Influenza
Table 1.  Two by Two table of ICD9s performance as 
a surveillance tool for Influenza.
PCR Positive 
Influenza
PCR Negative 
Influenza
ICD9 Positive for 
Influenza 664 339
PPV
0.662
ICD9 Negative 
for Influenza
791 15,449
NPV
0.951
Total Sensitivity 0.456
Specificity  
0.979
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dictive value of 73.7%. [8] Methods such as whole 
record surveillance using SNOMED CT have yielded 
better results with sensitivities of 92.9% in prior pu-
blications. In a previous study we demonstrated that 
SNOMED CT had good coverage, 98.7% sensitivity 
for the clinical content of chief complaints. [6] 
Influenza remains an important global public 
health problem and accurate surveillance coupled 
with a prompt public health response can decrease 
both morbidity and mortality from this disease.
Influenza like illness may represent exposure to 
agents of bioterrorism such as inhalational anthrax 
and can be an important indicator of a population’s 
exposure to such agents, especially if they occur in 
the non-Influenza season. 
From our data, ICD9-CM alone should not be 
used for the biosurveillance of Influenza or Influen-
za like illness. As only 8% of patients are labora-
tory tested for Influenza who are diagnosed with 
Influenza, laboratory surveillance alone although 
specific would be quite insensitive.
The formal Ontological understanding of the cli-
nical record stands as our best single tool in the 
fight to contain emerging infectious diseases. Bio-
surveillance leading to detection and an early public 
health response to Influenza can decrease morta-
lity and morbidity of the Influenza season. [5] NLP 
based Ontological surveillance using SNOMED CT 
has also been successfully used for fully automated 
electronic quality monitoring (eQuality). [9-11]
Further research is needed to identify the optimal 
combination of Ontological and direct coding sys-
tem evidence to predict Influenza and other emer-
ging infectious diseases. 
Conclusion
ICD9-CM had a low sensitivity (recall) and positive 
predictive value (precision) for the identification of 
true cases of Influenza in a population of patients 
tested for Influenza. However the negative predic-
tive value and specificity of ICD9-CM was strong. 
ICD9-CM should not be used alone for the survei-
llance of Influenza.
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